| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.738 | 0.005 | 0.738 | 5 Hydroxytryptamine release stimulant | 0.636 0.011 CID_86055599 | ||
| 0.543 | 0.018 | 0.543 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.439 0.069 CID_86055599 | ||
| 0.533 | 0.01 | 0.578 | Superoxide dismutase inhibitor | 0.578 0.008 CID_86055599 | CID_86055599 | |
| 0.501 | 0.018 | 0.501 | MAP kinase kinase 6 inhibitor | 0.387 0.066 CID_86055599 | ||
| 0.473 | 0.008 | 0.473 | Calcium channel activator | 0.453 0.01 CID_86055599 | ||
| 0.493 | 0.039 | 0.495 | Antiobesity | 0.495 0.038 CID_86055599 | CID_86055599 | |
| 0.495 | 0.051 | 0.495 | Analgesic | 0.328 0.122 CID_86055599 | ||
| 0.503 | 0.059 | 0.503 | Caspase 9 stimulant | 0.474 0.071 CID_86055599 | ||
| 0.453 | 0.02 | 0.453 | HERG channel blocker | 0.141 0.14 CID_86055599 | ||
| 0.393 | 0.028 | 0.393 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.366 | 0.006 | 0.366 | 5 Hydroxytryptamine agonist | 0.184 0.016 CID_86055599 | ||
| 0.412 | 0.073 | 0.414 | Calcium channel L-type activator | 0.414 0.072 CID_86055599 | CID_86055599 | |
| 0.325 | 0.008 | 0.325 | 5 Hydroxytryptamine 2C antagonist | 0.231 0.014 CID_86055599 | ||
| 0.381 | 0.07 | 0.385 | GABA C receptor rho-3 antagonist | 0.385 0.068 CID_86055599 | CID_86055599 | |
| 0.318 | 0.013 | 0.318 | 5 Hydroxytryptamine 2B antagonist | 0.264 0.017 CID_86055599 | ||
| 0.308 | 0.006 | 0.308 | Toll-Like receptor antagonist | 0.232 0.02 CID_86055599 | ||
| 0.381 | 0.091 | 0.381 | 5 Hydroxytryptamine release inhibitor | 0.326 0.138 CID_86055599 | ||
| 0.299 | 0.016 | 0.299 | 5 Hydroxytryptamine 2 antagonist | 0.219 0.026 CID_86055599 | ||
| 0.283 | 0.006 | 0.283 | 5 Hydroxytryptamine 7 antagonist | 0.175 0.015 CID_86055599 | ||
| 0.341 | 0.078 | 0.341 | Vasodilator, peripheral | 0.327 0.084 CID_86055599 | ||
| 0.284 | 0.021 | 0.284 | Focal adhesion kinase 2 inhibitor | 0.205 0.065 CID_86055599 | ||
| 0.311 | 0.056 | 0.311 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 CID_86055599 | ||
| 0.257 | 0.013 | 0.257 | 5 Hydroxytryptamine 3E antagonist | 0.211 0.046 CID_86055599 | ||
| 0.279 | 0.037 | 0.279 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.235 0.088 CID_86055599 | ||
| 0.264 | 0.023 | 0.264 | 5 Hydroxytryptamine antagonist | 0.166 0.043 CID_86055599 | ||
| 0.256 | 0.02 | 0.256 | Toll-Like receptor 9 antagonist | 0.169 0.051 CID_86055599 | ||
| 0.278 | 0.042 | 0.278 | MAP-kinase-activated kinase 5 inhibitor | 0.252 0.058 CID_86055599 | ||
| 0.24 | 0.004 | 0.24 | 5 Hydroxytryptamine 2C agonist | 0.158 0.005 CID_86055599 | ||
| 0.262 | 0.031 | 0.262 | I kappa B kinase epsilon inhibitor | 0.239 0.043 CID_86055599 | ||
| 0.278 | 0.047 | 0.278 | Anticonvulsant | 0.16 0.117 CID_86055599 | ||
| 0.234 | 0.008 | 0.234 | 5 Hydroxytryptamine 1F antagonist | 0.103 0.03 CID_86055599 | ||
| 0.239 | 0.016 | 0.239 | 5 Hydroxytryptamine 2A antagonist | 0.158 0.026 CID_86055599 | ||
| 0.243 | 0.022 | 0.243 | Activin receptor-like kinase 2 inhibitor | 0.196 0.038 CID_86055599 | ||
| 0.249 | 0.032 | 0.249 | Growth factor agonist | 0.202 0.061 CID_86055599 | ||
| 0.275 | 0.06 | 0.306 | 5 Hydroxytryptamine uptake stimulant | 0.306 0.042 CID_86055599 | CID_86055599 | |
| 0.244 | 0.03 | 0.244 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.099 CID_86055599 | ||
| 0.259 | 0.048 | 0.259 | Neuropeptide Y2 antagonist | 0.232 0.074 CID_86055599 | ||
| 0.215 | 0.011 | 0.215 | 5 Hydroxytryptamine 3A agonist | 0.181 0.021 CID_86055599 | ||
| 0.255 | 0.054 | 0.255 | EphB2 antagonist | |||
| 0.267 | 0.067 | 0.279 | Interleukin agonist | 0.279 0.06 CID_86055599 | CID_86055599 | |
| 0.211 | 0.015 | 0.211 | Ca(v)2.2 blocker | |||
| 0.25 | 0.054 | 0.25 | MAP kinase kinase 2 inhibitor | 0.209 0.076 CID_86055599 | ||
| 0.198 | 0.004 | 0.207 | 5 Hydroxytryptamine 2A agonist | 0.207 0.004 CID_86055599 | CID_86055599 | |
| 0.246 | 0.06 | 0.246 | Psychostimulant | 0.156 0.111 CID_86055599 | ||
| 0.216 | 0.03 | 0.231 | NADPH oxidase inhibitor | 0.231 0.025 CID_86055599 | CID_86055599 | |
| 0.252 | 0.066 | 0.252 | Potassium channel blocker | |||
| 0.251 | 0.067 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.28 0.044 CID_86055599 | CID_86055599 | |
| 0.196 | 0.013 | 0.196 | Protein kinase C mu inhibitor | 0.141 0.03 CID_86055599 | ||
| 0.208 | 0.026 | 0.208 | Sodium channel (voltage-gated) blocker | 0.131 0.073 CID_86055599 | ||
| 0.185 | 0.005 | 0.185 | Histone deacetylase SIRT1 stimulant | 0.137 0.012 CID_86055599 | ||
| 0.185 | 0.005 | 0.185 | Histone deacetylase stimulant | 0.137 0.012 CID_86055599 | ||
| 0.19 | 0.012 | 0.19 | 5 Hydroxytryptamine uptake inhibitor | 0.09 0.03 CID_86055599 | ||
| 0.181 | 0.004 | 0.181 | 5 Hydroxytryptamine 2 agonist | 0.131 0.006 CID_86055599 | ||
| 0.228 | 0.053 | 0.243 | Neurotrophic factor enhancer | 0.243 0.043 CID_86055599 | CID_86055599 | |
| 0.26 | 0.087 | 0.26 | Insulysin inhibitor | 0.239 0.107 CID_86055599 | ||
| 0.19 | 0.026 | 0.19 | Antiadrenergic | 0.116 0.047 CID_86055599 | ||
| 0.179 | 0.016 | 0.179 | Vanilloid antagonist | 0.08 0.047 CID_86055599 | ||
| 0.165 | 0.003 | 0.165 | 5 Hydroxytryptamine 2B agonist | 0.071 0.006 CID_86055599 | ||
| 0.187 | 0.026 | 0.187 | Adrenaline antagonist | 0.113 0.047 CID_86055599 | ||
| 0.179 | 0.019 | 0.179 | Pregnane X receptor agonist | 0.149 0.056 CID_86055599 | ||
| 0.163 | 0.005 | 0.163 | Neurokinin antagonist | 0.044 0.043 CID_86055599 | ||
| 0.224 | 0.066 | 0.224 | MAP kinase kinase 3 inhibitor | |||
| 0.269 | 0.112 | 0.285 | Cholesterol antagonist | 0.285 0.101 CID_86055599 | CID_86055599 | |
| 0.174 | 0.018 | 0.174 | Nav1.5 sodium channel blocker | 0.115 0.061 CID_86055599 | ||
| 0.241 | 0.085 | 0.241 | 5 Hydroxytryptamine 1E antagonist | 0.199 0.132 CID_86055599 | ||
| 0.194 | 0.038 | 0.194 | Cytokine production inhibitor | 0.147 0.065 CID_86055599 | ||
| 0.166 | 0.011 | 0.166 | 5 Hydroxytryptamine 1B antagonist | 0.073 0.039 CID_86055599 | ||
| 0.194 | 0.039 | 0.194 | Cyclin-dependent kinase 8 inhibitor | 0.149 0.08 CID_86055599 | ||
| 0.194 | 0.039 | 0.194 | Ribosomal protein S6 kinase inhibitor | 0.119 0.091 CID_86055599 | ||
| 0.173 | 0.02 | 0.173 | 5 Hydroxytryptamine 1 antagonist | 0.108 0.034 CID_86055599 | ||
| 0.172 | 0.02 | 0.172 | GABA C receptor antagonist | 0.146 0.032 CID_86055599 | ||
| 0.188 | 0.037 | 0.188 | Sodium channel blocker | 0.114 0.092 CID_86055599 | ||
| 0.182 | 0.034 | 0.22 | CF transmembrane conductance regulator agonist | 0.22 0.013 CID_86055599 | CID_86055599 | |
| 0.153 | 0.005 | 0.153 | Neurokinin 1 antagonist | |||
| 0.165 | 0.017 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.158 0.027 CID_86055599 | ||
| 0.187 | 0.039 | 0.187 | Nav1.2 sodium channel blocker | |||
| 0.165 | 0.018 | 0.165 | 5 Hydroxytryptamine 1A antagonist | 0.111 0.028 CID_86055599 | ||
| 0.163 | 0.017 | 0.163 | ALK inhibitor | 0.111 0.035 CID_86055599 | ||
| 0.149 | 0.004 | 0.149 | Toll-Like receptor 8 antagonist | 0.083 0.016 CID_86055599 | ||
| 0.162 | 0.021 | 0.189 | AMP-activated protein kinase stimulant | 0.189 0.013 CID_86055599 | CID_86055599 | |
| 0.146 | 0.005 | 0.146 | Acetylcholine M5 receptor agonist | 0.086 0.029 CID_86055599 | ||
| 0.147 | 0.006 | 0.147 | Toll-Like receptor 7 antagonist | 0.081 0.037 CID_86055599 | ||
| 0.155 | 0.015 | 0.155 | Alpha adrenoreceptor agonist | 0.124 0.021 CID_86055599 | ||
| 0.167 | 0.028 | 0.167 | GABA receptor agonist | 0.118 0.059 CID_86055599 | ||
| 0.17 | 0.032 | 0.17 | Alpha 2b adrenoreceptor antagonist | 0.107 0.069 CID_86055599 | ||
| 0.156 | 0.019 | 0.156 | Transcription factor STAT6 inhibitor | 0.154 0.021 CID_86055599 | ||
| 0.187 | 0.05 | 0.187 | MAP kinase kinase 5 inhibitor | |||
| 0.145 | 0.009 | 0.145 | Nicotinic alpha4beta2 receptor antagonist | 0.096 0.035 CID_86055599 | ||
| 0.246 | 0.112 | 0.246 | Nootropic | |||
| 0.163 | 0.029 | 0.179 | GABA C receptor agonist | 0.179 0.025 CID_86055599 | CID_86055599 | |
| 0.17 | 0.04 | 0.183 | Toll-Like receptor 2 antagonist | 0.183 0.032 CID_86055599 | CID_86055599 | |
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | |||
| 0.151 | 0.022 | 0.209 | Androgen antagonist | 0.209 0.013 CID_86055599 | CID_86055599 | |
| 0.143 | 0.016 | 0.143 | Vanilloid 1 antagonist | |||
| 0.238 | 0.111 | 0.325 | Hypoxia-inducible factor 1 alpha inhibitor | 0.325 0.055 CID_86055599 | CID_86055599 | |
| 0.135 | 0.008 | 0.135 | 5 Hydroxytryptamine 6 antagonist | 0.059 0.038 CID_86055599 | ||
| 0.212 | 0.085 | 0.212 | Cyclic AMP phosphodiesterase inhibitor | 0.188 0.103 CID_86055599 | ||
| 0.158 | 0.031 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.024 CID_86055599 | CID_86055599 | |
| 0.218 | 0.093 | 0.218 | Aryl hydrocarbon receptor agonist | 0.172 0.119 CID_86055599 | ||
| 0.159 | 0.035 | 0.159 | Alpha adrenoreceptor antagonist | 0.08 0.072 CID_86055599 | ||
| 0.14 | 0.016 | 0.14 | Dopamine D3 antagonist | 0.068 0.039 CID_86055599 | ||
| 0.149 | 0.026 | 0.149 | Dopamine antagonist | 0.09 0.043 CID_86055599 | ||
| 0.128 | 0.005 | 0.128 | Phospholipase D inhibitor | 0.095 0.018 CID_86055599 | ||
| 0.179 | 0.055 | 0.179 | Death-associated protein kinase 2 inhibitor | 0.174 0.062 CID_86055599 | ||
| 0.139 | 0.016 | 0.139 | Cyclin B3 inhibitor | 0.118 0.022 CID_86055599 | ||
| 0.166 | 0.047 | 0.166 | Calcium channel blocker | |||
| 0.148 | 0.03 | 0.148 | Activin receptor-like kinase 4 inhibitor | 0.109 0.068 CID_86055599 | ||
| 0.126 | 0.008 | 0.126 | 5 Hydroxytryptamine 3A antagonist | 0.062 0.053 CID_86055599 | ||
| 0.13 | 0.015 | 0.13 | 5 Hydroxytryptamine 1D antagonist | 0.062 0.047 CID_86055599 | ||
| 0.127 | 0.012 | 0.127 | 5 Hydroxytryptamine 1A agonist | 0.055 0.027 CID_86055599 | ||
| 0.147 | 0.033 | 0.147 | Alpha 2c adrenoreceptor antagonist | 0.095 0.07 CID_86055599 | ||
| 0.118 | 0.005 | 0.118 | Exportin-1 inhibitor | 0.071 0.04 CID_86055599 | ||
| 0.149 | 0.036 | 0.149 | Polo-like kinase-4 inhibitor | 0.1 0.077 CID_86055599 | ||
| 0.116 | 0.004 | 0.116 | Vascular adhesion protein 1 inhibitor | 0.053 0.013 CID_86055599 | ||
| 0.143 | 0.031 | 0.143 | Alpha 1 adrenoreceptor antagonist | |||
| 0.137 | 0.026 | 0.137 | Alpha 1a adrenoreceptor antagonist | |||
| 0.136 | 0.025 | 0.136 | Alpha 2a adrenoreceptor antagonist | 0.084 0.046 CID_86055599 | ||
| 0.126 | 0.016 | 0.126 | 5 Hydroxytryptamine 1 agonist | |||
| 0.134 | 0.025 | 0.134 | Stem cell growth factor agonist | 0.077 0.07 CID_86055599 | ||
| 0.132 | 0.022 | 0.132 | Potassium channel (Voltage-sensitive) activator | |||
| 0.131 | 0.023 | 0.131 | Acetylcholine nicotinic agonist | 0.073 0.066 CID_86055599 | ||
| 0.141 | 0.033 | 0.141 | CDK3/cyclin E inhibitor | 0.12 0.056 CID_86055599 | ||
| 0.147 | 0.04 | 0.147 | Calcium channel N-type blocker | |||
| 0.132 | 0.026 | 0.132 | Alpha 1b adrenoreceptor antagonist | 0.065 0.056 CID_86055599 | ||
| 0.11 | 0.004 | 0.11 | Purinergic P2X4 antagonist | 0.092 0.005 CID_86055599 | ||
| 0.123 | 0.02 | 0.123 | Nav1.8 sodium channel blocker | 0.082 0.04 CID_86055599 | ||
| 0.109 | 0.006 | 0.109 | 5 Hydroxytryptamine 7 agonist | 0.084 0.011 CID_86055599 | ||
| 0.16 | 0.056 | 0.16 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.155 | 0.053 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.049 CID_86055599 | CID_86055599 | |
| 0.133 | 0.031 | 0.133 | Hedgehog signaling inhibitor | |||
| 0.126 | 0.025 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.068 CID_86055599 | ||
| 0.113 | 0.013 | 0.113 | Ca(v)3.1 blocker | 0.092 0.033 CID_86055599 | ||
| 0.117 | 0.017 | 0.117 | Nav1.7 sodium channel blocker | 0.063 0.054 CID_86055599 | ||
| 0.112 | 0.012 | 0.112 | Calcium channel T-type blocker | |||
| 0.172 | 0.072 | 0.172 | Antipruritic | |||
| 0.127 | 0.027 | 0.127 | Pim-3 kinase inhibitor | 0.11 0.037 CID_86055599 | ||
| 0.171 | 0.072 | 0.204 | Phospholipase C inhibitor | 0.204 0.042 CID_86055599 | CID_86055599 | |
| 0.129 | 0.03 | 0.129 | Electrolyte absorption antagonist | 0.111 0.044 CID_86055599 | ||
| 0.123 | 0.024 | 0.123 | MAP-kinase-activated kinase inhibitor | 0.078 0.065 CID_86055599 | ||
| 0.164 | 0.066 | 0.164 | Cytidine deaminase inhibitor | |||
| 0.149 | 0.05 | 0.149 | TRKA antagonist | |||
| 0.147 | 0.049 | 0.147 | Nav1.3 sodium channel blocker | |||
| 0.109 | 0.012 | 0.109 | 5 Hydroxytryptamine 3 agonist | 0.075 0.031 CID_86055599 | ||
| 0.122 | 0.025 | 0.122 | Bcr-Abl kinase inhibitor | 0.12 0.026 CID_86055599 | ||
| 0.109 | 0.011 | 0.109 | CC chemokine 2 receptor antagonist | 0.049 0.046 CID_86055599 | ||
| 0.145 | 0.048 | 0.145 | Death-associated protein kinase 1 inhibitor | 0.125 0.098 CID_86055599 | ||
| 0.111 | 0.014 | 0.111 | Alpha 1 adrenoreceptor agonist | 0.07 0.028 CID_86055599 | ||
| 0.137 | 0.041 | 0.137 | Calcium channel (voltage-sensitive) blocker | |||
| 0.12 | 0.024 | 0.12 | GABA A receptor agonist | 0.084 0.056 CID_86055599 | ||
| 0.099 | 0.003 | 0.099 | Nerve growth factor antagonist | 0.066 0.006 CID_86055599 | ||
| 0.132 | 0.036 | 0.164 | Beta glucuronidase inhibitor | 0.164 0.02 CID_86055599 | CID_86055599 | |
| 0.1 | 0.005 | 0.1 | Substance P antagonist | |||
| 0.124 | 0.03 | 0.137 | Protein kinase C zeta inhibitor | 0.137 0.024 CID_86055599 | CID_86055599 | |
| 0.107 | 0.014 | 0.107 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.042 CID_86055599 | ||
| 0.128 | 0.035 | 0.128 | Interleukin 2 antagonist | |||
| 0.126 | 0.034 | 0.126 | Alpha 2 adrenoreceptor antagonist | 0.081 0.065 CID_86055599 | ||
| 0.127 | 0.037 | 0.157 | Potassium channel (Ca-activated) activator | 0.157 0.026 CID_86055599 | CID_86055599 | |
| 0.205 | 0.115 | 0.235 | DNA synthesis inhibitor | 0.235 0.078 CID_86055599 | CID_86055599 | |
| 0.097 | 0.007 | 0.097 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 CID_86055599 | ||
| 0.124 | 0.034 | 0.124 | Protein kinase C delta inhibitor | 0.115 0.04 CID_86055599 | ||
| 0.162 | 0.072 | 0.162 | Polo-like kinase-3 inhibitor | |||
| 0.168 | 0.079 | 0.168 | Tumour necrosis factor antagonist | 0.137 0.118 CID_86055599 | ||
| 0.114 | 0.026 | 0.114 | Glutamate release inhibitor | 0.105 0.035 CID_86055599 | ||
| 0.111 | 0.023 | 0.111 | MAP-kinase-activated kinase 2 inhibitor | 0.067 0.063 CID_86055599 | ||
| 0.101 | 0.014 | 0.101 | Alpha 2 adrenoreceptor agonist | 0.08 0.024 CID_86055599 | ||
| 0.095 | 0.008 | 0.095 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CID_86055599 | ||
| 0.096 | 0.01 | 0.096 | Histamine agonist | |||
| 0.129 | 0.043 | 0.129 | Nav1.1 sodium channel blocker | 0.111 0.055 CID_86055599 | ||
| 0.132 | 0.046 | 0.132 | Ferrochelatase inhibitor | |||
| 0.095 | 0.009 | 0.095 | Cyclin D1 inhibitor | 0.088 0.012 CID_86055599 | ||
| 0.101 | 0.015 | 0.101 | 5 Hydroxytryptamine 5 antagonist | 0.054 0.047 CID_86055599 | ||
| 0.117 | 0.032 | 0.117 | Interleukin 12 antagonist | 0.105 0.046 CID_86055599 | ||
| 0.149 | 0.065 | 0.149 | Tyrosine-protein kinase receptor antagonist | |||
| 0.108 | 0.024 | 0.108 | Focal adhesion kinase 1 inhibitor | 0.069 0.064 CID_86055599 | ||
| 0.105 | 0.022 | 0.105 | Alpha 1d adrenoreceptor antagonist | |||
| 0.163 | 0.081 | 0.163 | ATPase inhibitor | 0.149 0.103 CID_86055599 | ||
| 0.128 | 0.046 | 0.135 | Protein kinase C gamma inhibitor | 0.135 0.041 CID_86055599 | CID_86055599 | |
| 0.111 | 0.029 | 0.111 | Dopamine D2 antagonist | 0.065 0.046 CID_86055599 | ||
| 0.141 | 0.061 | 0.141 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 CID_86055599 | ||
| 0.207 | 0.128 | 0.21 | Transcription factor STAT inhibitor | 0.21 0.124 CID_86055599 | CID_86055599 | |
| 0.09 | 0.01 | 0.09 | Ca(v)3.2 blocker | 0.068 0.026 CID_86055599 | ||
| 0.115 | 0.036 | 0.115 | Potassium channel activator | 0.087 0.065 CID_86055599 | ||
| 0.116 | 0.037 | 0.116 | Calcium antagonist | |||
| 0.132 | 0.055 | 0.132 | Beta amyloid protein antagonist | 0.116 0.072 CID_86055599 | ||
| 0.084 | 0.007 | 0.084 | Histamine H4 receptor antagonist | 0.046 0.038 CID_86055599 | ||
| 0.085 | 0.009 | 0.085 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.085 | 0.01 | 0.085 | Stearoyl-CoA desaturase inhibitor | 0.05 0.023 CID_86055599 | ||
| 0.098 | 0.023 | 0.098 | Protein kinase C alpha inhibitor | 0.087 0.029 CID_86055599 | ||
| 0.111 | 0.036 | 0.111 | Polo-like kinase-1 inhibitor | |||
| 0.089 | 0.015 | 0.089 | Cyclin-dependent kinase 6 inhibitor | 0.07 0.031 CID_86055599 | ||
| 0.082 | 0.009 | 0.082 | Neurokinin 3 antagonist | |||
| 0.103 | 0.03 | 0.103 | NMDA 2 receptor antagonist | 0.102 0.031 CID_86055599 | ||
| 0.092 | 0.02 | 0.092 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.173 | 0.101 | 0.173 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.097 | 0.025 | 0.097 | CC chemokine 5 receptor agonist | 0.086 0.046 CID_86055599 | ||
| 0.097 | 0.026 | 0.097 | Neuronal nicotinic receptor antagonist | 0.074 0.042 CID_86055599 | ||
| 0.15 | 0.079 | 0.168 | Hexokinase inhibitor | 0.168 0.06 CID_86055599 | CID_86055599 | |
| 0.075 | 0.004 | 0.075 | Vanilloid 4 antagonist | 0.035 0.018 CID_86055599 | ||
| 0.09 | 0.02 | 0.092 | Protein kinase C beta inhibitor | 0.092 0.018 CID_86055599 | CID_86055599 | |
| 0.08 | 0.01 | 0.08 | Kinesin antagonist | 0.045 0.019 CID_86055599 | ||
| 0.08 | 0.01 | 0.08 | Kinesin-like protein 1 inhibitor | 0.045 0.019 CID_86055599 | ||
| 0.147 | 0.078 | 0.147 | GABA C receptor rho-2 antagonist | 0.133 0.101 CID_86055599 | ||
| 0.114 | 0.045 | 0.114 | GABA C receptor rho-1 antagonist | 0.098 0.065 CID_86055599 | ||
| 0.083 | 0.014 | 0.083 | Sphingosine kinase 2 inhibitor | 0.083 0.014 CID_86055599 | ||
| 0.107 | 0.039 | 0.107 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.113 | 0.044 | 0.129 | HIV-1 integrase (Overall Integration) inhibitor | 0.129 0.034 CID_86055599 | CID_86055599 | |
| 0.22 | 0.152 | 0.22 | Ca(v)3.3 blocker | |||
| 0.091 | 0.023 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_86055599 | CID_86055599 | |
| 0.114 | 0.047 | 0.114 | Insulin receptor antagonist | |||
| 0.087 | 0.02 | 0.112 | Androgen agonist | 0.112 0.011 CID_86055599 | CID_86055599 | |
| 0.133 | 0.067 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.103 | 0.038 | 0.103 | Acetylcholine nicotinic antagonist | 0.074 0.063 CID_86055599 | ||
| 0.094 | 0.028 | 0.094 | Cyclin-dependent kinase 4 inhibitor | 0.063 0.048 CID_86055599 | ||
| 0.084 | 0.019 | 0.084 | Nicotinic neuronal receptor agonist | |||
| 0.082 | 0.018 | 0.082 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.081 0.019 CID_86055599 | ||
| 0.099 | 0.035 | 0.1 | Myeloperoxidase inhibitor | 0.1 0.035 CID_86055599 | CID_86055599 | |
| 0.112 | 0.048 | 0.112 | Pim-1 kinase inhibitor | 0.096 0.062 CID_86055599 | ||
| 0.081 | 0.018 | 0.081 | MDM2 inhibitor | 0.064 0.058 CID_86055599 | ||
| 0.07 | 0.007 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.042 0.023 CID_86055599 | ||
| 0.118 | 0.055 | 0.118 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.073 | 0.011 | 0.073 | CC chemokine receptor 2B antagonist | 0.047 0.038 CID_86055599 | ||
| 0.067 | 0.005 | 0.067 | Histamine H1 receptor agonist | |||
| 0.093 | 0.031 | 0.093 | Syk tyrosine kinase inhibitor | 0.063 0.057 CID_86055599 | ||
| 0.086 | 0.024 | 0.086 | Adrenaline uptake inhibitor | 0.059 0.046 CID_86055599 | ||
| 0.076 | 0.014 | 0.076 | Epithelial sodium channel blocker | 0.076 0.014 CID_86055599 | ||
| 0.063 | 0.002 | 0.083 | Estrogen-related receptor gamma antagonist | 0.083 0.002 CID_86055599 | CID_86055599 | |
| 0.135 | 0.074 | 0.135 | Aurora-C kinase inhibitor | |||
| 0.087 | 0.026 | 0.087 | MAP kinase 7 inhibitor | |||
| 0.075 | 0.015 | 0.075 | Nicotinic receptor alpha4 subunit antagonist | 0.05 0.033 CID_86055599 | ||
| 0.068 | 0.009 | 0.068 | GABA B receptor antagonist | 0.04 0.035 CID_86055599 | ||
| 0.071 | 0.012 | 0.071 | Adenylate cyclase 1 inhibitor | 0.043 0.038 CID_86055599 | ||
| 0.099 | 0.041 | 0.099 | Bromodomain-containing protein 2 inhibitor | |||
| 0.152 | 0.094 | 0.152 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.108 | 0.051 | 0.156 | Creatine kinase inhibitor | 0.156 0.021 CID_86055599 | CID_86055599 | |
| 0.102 | 0.045 | 0.102 | Acetylcholine agonist | |||
| 0.112 | 0.055 | 0.112 | Check point kinase 2 inhibitor | |||
| 0.06 | 0.004 | 0.06 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 CID_86055599 | ||
| 0.059 | 0.005 | 0.059 | Cholesterol ester transfer protein antagonist | 0.05 0.007 CID_86055599 | ||
| 0.101 | 0.047 | 0.101 | Alpha 2d adrenoreceptor antagonist | |||
| 0.08 | 0.026 | 0.08 | Aryl hydrocarbon receptor antagonist | |||
| 0.057 | 0.004 | 0.057 | Apolipoprotein B inhibitor | |||
| 0.091 | 0.039 | 0.091 | Fibroblast growth factor 3 antagonist | |||
| 0.071 | 0.019 | 0.071 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.138 | 0.087 | 0.138 | Acetylcholine M1 receptor antagonist | 0.118 0.111 CID_86055599 | ||
| 0.057 | 0.005 | 0.057 | Purinergic P2Y14 antagonist | 0.027 0.025 CID_86055599 | ||
| 0.055 | 0.004 | 0.055 | Imidazoline I1 receptor antagonist | 0.023 0.012 CID_86055599 | ||
| 0.069 | 0.018 | 0.069 | Lysine-specific demethylase 1A inhibitor | 0.053 0.038 CID_86055599 | ||
| 0.119 | 0.069 | 0.119 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.077 | 0.027 | 0.077 | TRPA1 antagonist | 0.054 0.052 CID_86055599 | ||
| 0.058 | 0.009 | 0.058 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.07 | 0.021 | 0.07 | Glycine transporter 2 inhibitor | 0.047 0.033 CID_86055599 | ||
| 0.216 | 0.168 | 0.216 | Vasodilator, coronary | |||
| 0.053 | 0.005 | 0.061 | Estrogen-related receptor beta antagonist | 0.061 0.004 CID_86055599 | CID_86055599 | |
| 0.132 | 0.084 | 0.132 | Cell wall synthesis inhibitor | |||
| 0.075 | 0.028 | 0.075 | CDK4/cyclin D1 inhibitor | 0.066 0.034 CID_86055599 | ||
| 0.058 | 0.011 | 0.058 | Potassium channel KCNQ activator | |||
| 0.058 | 0.011 | 0.058 | Delayed rectifier potassium channel activator | |||
| 0.07 | 0.023 | 0.07 | Cyclin A1 inhibitor | |||
| 0.069 | 0.024 | 0.069 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.061 | 0.016 | 0.061 | Cholesterol esterase inhibitor | 0.047 0.034 CID_86055599 | ||
| 0.148 | 0.103 | 0.148 | TRKC antagonist | |||
| 0.066 | 0.022 | 0.066 | Glycine transporter inhibitor | |||
| 0.082 | 0.038 | 0.082 | Calcium channel L-type blocker | |||
| 0.066 | 0.023 | 0.066 | Myc inhibitor | 0.052 0.041 CID_86055599 | ||
| 0.113 | 0.071 | 0.113 | Interleukin 8 antagonist | 0.105 0.087 CID_86055599 | ||
| 0.051 | 0.008 | 0.051 | CF transmembrane conductance regulator antagonist | 0.051 0.007 CID_86055599 | ||
| 0.067 | 0.024 | 0.067 | Glucosylceramidase inhibitor | 0.06 0.031 CID_86055599 | ||
| 0.066 | 0.024 | 0.066 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.046 | 0.004 | 0.046 | Apolipoprotein B-100 inhibitor | |||
| 0.045 | 0.004 | 0.045 | Acid ceramidase inhibitor | 0.026 0.016 CID_86055599 | ||
| 0.177 | 0.135 | 0.178 | Nitric-oxide synthase stimulant | 0.178 0.133 CID_86055599 | CID_86055599 | |
| 0.069 | 0.028 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.046 | 0.005 | 0.046 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.013 CID_86055599 | ||
| 0.069 | 0.029 | 0.069 | Cyclin H inhibitor | 0.057 0.044 CID_86055599 | ||
| 0.052 | 0.012 | 0.052 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 CID_86055599 | ||
| 0.049 | 0.009 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 CID_86055599 | CID_86055599 | |
| 0.045 | 0.005 | 0.045 | 5 Hydroxytryptamine 6 agonist | |||
| 0.063 | 0.024 | 0.063 | Pregnane X receptor antagonist | 0.057 0.037 CID_86055599 | ||
| 0.053 | 0.013 | 0.053 | Alpha 1L adrenoreceptor agonist | 0.046 0.024 CID_86055599 | ||
| 0.092 | 0.052 | 0.096 | NMDA receptor antagonist | 0.096 0.05 CID_86055599 | CID_86055599 | |
| 0.045 | 0.006 | 0.045 | Calcium-sensing receptor agonist | |||
| 0.074 | 0.035 | 0.074 | Dopamine D4 antagonist | |||
| 0.075 | 0.036 | 0.104 | Dopamine D1 antagonist | 0.104 0.024 CID_86055599 | CID_86055599 | |
| 0.089 | 0.05 | 0.089 | TIE antagonist | |||
| 0.08 | 0.041 | 0.086 | GABA B receptor agonist | 0.086 0.032 CID_86055599 | CID_86055599 | |
| 0.077 | 0.039 | 0.077 | Orexin receptor 1 antagonist | |||
| 0.078 | 0.04 | 0.078 | Potassium channel (Tandem pore domain) blocker | |||
| 0.058 | 0.021 | 0.058 | Alpha 1b adrenoreceptor agonist | 0.048 0.04 CID_86055599 | ||
| 0.088 | 0.051 | 0.094 | mTOR complex 2 inhibitor | 0.094 0.041 CID_86055599 | CID_86055599 | |
| 0.134 | 0.098 | 0.134 | MAP kinase 3 inhibitor | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate oxidase inhibitor | 0.06 0.03 CID_86055599 | ||
| 0.147 | 0.112 | 0.178 | Catenin beta inhibitor | 0.178 0.054 CID_86055599 | CID_86055599 | |
| 0.054 | 0.019 | 0.054 | Cyclin D3 inhibitor | |||
| 0.141 | 0.107 | 0.141 | LIM domain kinase 1 inhibitor | |||
| 0.096 | 0.062 | 0.096 | Phosphodiesterase 7B inhibitor | |||
| 0.065 | 0.032 | 0.065 | CDK4/cyclin D inhibitor | 0.056 0.044 CID_86055599 | ||
| 0.037 | 0.004 | 0.037 | Nicotinic alpha4 receptor agonist | 0.018 0.009 CID_86055599 | ||
| 0.075 | 0.043 | 0.075 | CDK1/cyclin B1 inhibitor | |||
| 0.065 | 0.033 | 0.065 | Potassium channel (Ca-activated) blocker | |||
| 0.064 | 0.032 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.02 CID_86055599 | CID_86055599 | |
| 0.086 | 0.055 | 0.086 | Acetylcholine M3 receptor agonist | |||
| 0.047 | 0.016 | 0.047 | Somatostatin 4 agonist | |||
| 0.067 | 0.036 | 0.067 | Cyclin B1 inhibitor | 0.057 0.048 CID_86055599 | ||
| 0.089 | 0.058 | 0.1 | NADH dehydrogenase inhibitor | 0.1 0.044 CID_86055599 | CID_86055599 | |
| 0.056 | 0.025 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.035 | 0.005 | 0.035 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.066 | 0.035 | 0.066 | Histone deacetylase SIRT3 inhibitor | |||
| 0.042 | 0.012 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.028 CID_86055599 | ||
| 0.052 | 0.022 | 0.052 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.043 | 0.013 | 0.043 | 5 Hydroxytryptamine 1D agonist | |||
| 0.083 | 0.054 | 0.083 | TIE-2 antagonist | |||
| 0.044 | 0.015 | 0.075 | Estrogen-related receptor alpha antagonist | 0.075 0.009 CID_86055599 | CID_86055599 | |
| 0.046 | 0.017 | 0.046 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.053 | 0.024 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.081 | 0.055 | 0.081 | Glycine receptor antagonist | 0.077 0.061 CID_86055599 | ||
| 0.045 | 0.018 | 0.045 | Diamine oxidase inhibitor | |||
| 0.07 | 0.044 | 0.104 | Potassium channel large-conductance Ca-activated activator | 0.104 0.022 CID_86055599 | CID_86055599 | |
| 0.095 | 0.068 | 0.095 | Chemokine receptor antagonist | |||
| 0.057 | 0.031 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.063 | 0.038 | 0.063 | Heme oxygenase stimulant | 0.062 0.04 CID_86055599 | ||
| 0.129 | 0.103 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.058 | 0.033 | 0.058 | Pim-2 kinase inhibitor | |||
| 0.065 | 0.039 | 0.065 | Cannabinoid CB1 receptor antagonist | |||
| 0.105 | 0.08 | 0.105 | Adenylate cyclase inhibitor | 0.101 0.084 CID_86055599 | ||
| 0.045 | 0.02 | 0.045 | Glutamate (mGluR group II) antagonist | 0.043 0.022 CID_86055599 | ||
| 0.114 | 0.089 | 0.114 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.074 | 0.05 | 0.074 | Polo-like kinase-2 inhibitor | |||
| 0.04 | 0.017 | 0.04 | Ceramide glucosyltransferase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Purinergic P2X antagonist | |||
| 0.06 | 0.038 | 0.06 | Dopamine uptake inhibitor | |||
| 0.096 | 0.075 | 0.096 | Adenylate kinase inhibitor | 0.092 0.083 CID_86055599 | ||
| 0.042 | 0.022 | 0.042 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.051 | 0.031 | 0.051 | Sodium/calcium exchanger inhibitor | |||
| 0.044 | 0.024 | 0.05 | Sphingosine kinase 1 inhibitor | 0.05 0.017 CID_86055599 | CID_86055599 | |
| 0.045 | 0.026 | 0.045 | Neurokinin 2 antagonist | |||
| 0.081 | 0.061 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.081 | 0.062 | 0.081 | T cell inhibitor | |||
| 0.076 | 0.057 | 0.106 | Macrophage migration inhibitory factor inhibitor | 0.106 0.032 CID_86055599 | CID_86055599 | |
| 0.073 | 0.054 | 0.073 | Acetylcholine M4 receptor antagonist | |||
| 0.076 | 0.058 | 0.076 | Viral attachment inhibitor | |||
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | |||
| 0.06 | 0.043 | 0.06 | CXC chemokine 4 receptor antagonist | |||
| 0.092 | 0.075 | 0.092 | Nitric-oxide synthase inhibitor | |||
| 0.065 | 0.048 | 0.065 | Orexin receptor antagonist | |||
| 0.078 | 0.061 | 0.078 | Neuropeptide Y antagonist | |||
| 0.036 | 0.02 | 0.036 | CDK6/cyclin D3 inhibitor | |||
| 0.034 | 0.018 | 0.034 | Acetylcholine M4 receptor agonist | |||
| 0.053 | 0.037 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.066 | 0.05 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.043 | 0.027 | 0.055 | Liver X receptor alpha agonist | 0.055 0.015 CID_86055599 | CID_86055599 | |
| 0.062 | 0.046 | 0.062 | Purinergic P2 antagonist | |||
| 0.049 | 0.033 | 0.079 | Plasminogen activator inhibitor antagonist | 0.079 0.015 CID_86055599 | CID_86055599 | |
| 0.032 | 0.016 | 0.032 | CDK4/cyclin D3 inhibitor | |||
| 0.033 | 0.018 | 0.033 | Epoxide hydrolase 1 inhibitor | |||
| 0.023 | 0.007 | 0.023 | Alpha 2a adrenoreceptor agonist | |||
| 0.029 | 0.014 | 0.029 | Glucosylceramidase stimulant | |||
| 0.05 | 0.035 | 0.05 | Dopamine D4 agonist | |||
| 0.032 | 0.017 | 0.032 | Cyclin E2 inhibitor | |||
| 0.019 | 0.004 | 0.019 | Imidazoline I2 receptor antagonist | |||
| 0.034 | 0.019 | 0.037 | Liver X receptor antagonist | 0.037 0.015 CID_86055599 | CID_86055599 | |
| 0.058 | 0.043 | 0.1 | Heat shock protein 90 beta antagonist | 0.1 0.011 CID_86055599 | CID_86055599 | |
| 0.114 | 0.099 | 0.124 | Protein kinase stimulant | 0.124 0.089 CID_86055599 | CID_86055599 | |
| 0.018 | 0.004 | 0.018 | Cyclin D2 inhibitor | 0.014 0.008 CID_86055599 | ||
| 0.08 | 0.067 | 0.08 | Insulin growth factor antagonist | |||
| 0.032 | 0.019 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.067 | 0.053 | 0.067 | Prostaglandin-E synthase inhibitor | |||
| 0.031 | 0.017 | 0.035 | Liver X receptor alpha antagonist | 0.035 0.013 CID_86055599 | CID_86055599 | |
| 0.054 | 0.041 | 0.054 | Cyclin B2 inhibitor | |||
| 0.073 | 0.06 | 0.073 | Glutamate receptor agonist | |||
| 0.031 | 0.018 | 0.031 | Glutamate (mGluR2) antagonist | 0.028 0.024 CID_86055599 | ||
| 0.037 | 0.024 | 0.037 | Purinergic P2X7 antagonist | |||
| 0.04 | 0.027 | 0.06 | Dopamine D5 agonist | 0.06 0.012 CID_86055599 | CID_86055599 | |
| 0.106 | 0.093 | 0.106 | TRKB antagonist | |||
| 0.033 | 0.02 | 0.033 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.054 | 0.042 | 0.054 | MAP kinase kinase 9 inhibitor | |||
| 0.068 | 0.056 | 0.068 | Epoxide hydrolase inhibitor | |||
| 0.053 | 0.041 | 0.053 | Cyclin B inhibitor | |||
| 0.07 | 0.059 | 0.07 | CYP2A6 inhibitor | |||
| 0.055 | 0.044 | 0.055 | EphB4 antagonist | |||
| 0.084 | 0.072 | 0.084 | Antihistaminic | |||
| 0.079 | 0.068 | 0.079 | Histamine N-methyltransferase inhibitor | |||
| 0.038 | 0.027 | 0.038 | TRPM8 blocker | |||
| 0.029 | 0.018 | 0.029 | LFA antagonist | |||
| 0.043 | 0.033 | 0.043 | Purinergic P2Y antagonist | |||
| 0.043 | 0.033 | 0.043 | Dipeptidyl peptidase IV inhibitor | |||
| 0.055 | 0.045 | 0.055 | Protein kinase C theta inhibitor | |||
| 0.138 | 0.127 | 0.154 | Anesthetic general | 0.154 0.109 CID_86055599 | CID_86055599 | |
| 0.061 | 0.051 | 0.061 | Transcription factor RelA inhibitor | |||
| 0.024 | 0.014 | 0.024 | ICAM 1 antagonist | |||
| 0.033 | 0.023 | 0.042 | Liver X receptor beta agonist | 0.042 0.014 CID_86055599 | CID_86055599 | |
| 0.147 | 0.137 | 0.147 | Insulin sensitizer | |||
| 0.109 | 0.099 | 0.131 | DNA repair enzyme inhibitor | 0.131 0.053 CID_86055599 | CID_86055599 | |
| 0.029 | 0.019 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.022 | 0.012 | 0.022 | Factor XIII inhibitor | |||
| 0.018 | 0.008 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.076 | 0.067 | 0.076 | Insulin like growth factor 1 antagonist | |||
| 0.091 | 0.082 | 0.091 | Glutamate (mGluR7) agonist | |||
| 0.045 | 0.036 | 0.045 | Aldosterone antagonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.065 | 0.057 | 0.065 | Amidase inhibitor | |||
| 0.087 | 0.079 | 0.087 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.205 | 0.197 | 0.213 | Histamine release inhibitor | 0.213 0.188 CID_86055599 | CID_86055599 | |
| 0.038 | 0.031 | 0.038 | Kainate receptor antagonist | |||
| 0.036 | 0.029 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.119 | 0.112 | 0.119 | Insulin secretagoues | |||
| 0.062 | 0.054 | 0.062 | CDC7 inhibitor | |||
| 0.085 | 0.078 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.061 | 0.054 | 0.061 | Calcium channel P-type blocker | |||
| 0.033 | 0.026 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.015 CID_86055599 | CID_86055599 | |
| 0.054 | 0.047 | 0.054 | Raf kinase C inhibitor | |||
| 0.046 | 0.04 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.039 CID_86055599 | ||
| 0.037 | 0.032 | 0.037 | Nicotinic acid receptor 1 agonist | |||
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.073 | 0.068 | 0.126 | Adrenaline agonist | 0.126 0.023 CID_86055599 | CID_86055599 | |
| 0.098 | 0.093 | 0.098 | Acetylcholine release stimulant | |||
| 0.025 | 0.021 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.067 | 0.064 | 0.067 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.074 | 0.071 | 0.074 | Histamine antagonist | |||
| 0.036 | 0.033 | 0.036 | Vanilloid 3 antagonist | |||
| 0.042 | 0.04 | 0.042 | Parathyroid hormone antagonist | |||
| 0.018 | 0.015 | 0.025 | Estrogen-related receptor gamma agonist | 0.025 0.005 CID_86055599 | CID_86055599 | |
| 0.039 | 0.037 | 0.045 | Liver X receptor agonist | 0.045 0.028 CID_86055599 | CID_86055599 | |
| 0.042 | 0.04 | 0.043 | AMPA receptor antagonist | 0.043 0.039 CID_86055599 | CID_86055599 | |
| 0.138 | 0.136 | 0.148 | Neurotensin receptor agonist | 0.148 0.107 CID_86055599 | CID_86055599 | |
| 0.103 | 0.101 | 0.103 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.048 | 0.046 | 0.048 | Nicotinic alpha7 receptor agonist | |||
| 0.03 | 0.028 | 0.034 | Protein kinase C beta II inhibitor | 0.034 0.018 CID_86055599 | CID_86055599 | |
| 0.039 | 0.038 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.02 | 0.019 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.069 | 0.068 | 0.069 | Vanilloid 4 agonist | |||
| 0.114 | 0.113 | 0.118 | Mannose-6-phosphate isomerase inhibitor | 0.118 0.104 CID_86055599 | CID_86055599 | |
| 0.031 | 0.03 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.022 | 0.021 | 0.022 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.048 | 0.047 | 0.048 | NMDA 2B receptor antagonist | |||
| 0.048 | 0.05 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.056 0.04 CID_86055599 | CID_86055599 | |
| 0.069 | 0.071 | 0.12 | Estrogen receptor alpha antagonist | 0.12 0.019 CID_86055599 | CID_86055599 | |
| 0.079 | 0.081 | 0.093 | Alcohol dehydrogenase inhibitor | 0.093 0.06 CID_86055599 | CID_86055599 | |
| 0.032 | 0.035 | 0.035 | Glutamate (mGluR3) antagonist | 0.035 0.028 CID_86055599 | CID_86055599 | |
| 0.082 | 0.086 | 0.112 | UDP-glucose 4-epimerase inhibitor | 0.112 0.049 CID_86055599 | CID_86055599 | |
| 0.043 | 0.048 | 0.056 | Topoisomerase II beta inhibitor | 0.056 0.025 CID_86055599 | CID_86055599 | |
| 0.052 | 0.059 | 0.065 | Purinergic P2X1 antagonist | 0.065 0.037 CID_86055599 | CID_86055599 | |
| 0.017 | 0.024 | 0.037 | Urotensin II antagonist | 0.037 0.008 CID_86055599 | CID_86055599 | |
| 0.016 | 0.024 | 0.019 | Progesterone receptor B antagonist | 0.019 0.014 CID_86055599 | CID_86055599 | |
| 0.026 | 0.034 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.03 0.025 CID_86055599 | CID_86055599 | |
| 0.119 | 0.129 | 0.175 | Heat shock protein 90 alpha antagonist | 0.175 0.066 CID_86055599 | CID_86055599 | |
| 0.034 | 0.045 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.037 CID_86055599 | CID_86055599 | |
| 0.044 | 0.055 | 0.065 | Protein kinase C eta inhibitor | 0.065 0.031 CID_86055599 | CID_86055599 | |
| 0.075 | 0.087 | 0.094 | Estrogen-related receptor beta agonist | 0.094 0.032 CID_86055599 | CID_86055599 | |
| 0.05 | 0.062 | 0.072 | Dopamine agonist | 0.072 0.042 CID_86055599 | CID_86055599 | |
| 0.124 | 0.139 | 0.137 | Interleukin 6 antagonist | 0.137 0.111 CID_86055599 | CID_86055599 | |
| 0.035 | 0.051 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 CID_86055599 | CID_86055599 | |
| 0.035 | 0.053 | 0.047 | DNA gyrase subunit A inhibitor | 0.047 0.021 CID_86055599 | CID_86055599 | |
| 0.15 | 0.173 | 0.178 | DNA damaging | 0.178 0.137 CID_86055599 | CID_86055599 | |
| 0.035 | 0.061 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 CID_86055599 | CID_86055599 | |
| 0.1 | 0.126 | 0.175 | Peroxidase inhibitor | 0.175 0.067 CID_86055599 | CID_86055599 | |
| 0.05 | 0.077 | 0.057 | Ryanodine receptor antagonist | 0.057 0.046 CID_86055599 | CID_86055599 | |
| 0.026 | 0.054 | 0.043 | Dopamine D2 agonist | 0.043 0.032 CID_86055599 | CID_86055599 | |
| 0.113 | 0.142 | 0.14 | Adenylate cyclase stimulant | 0.14 0.082 CID_86055599 | CID_86055599 | |
| 0.071 | 0.102 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.043 CID_86055599 | CID_86055599 | |
| 0.133 | 0.169 | 0.218 | Antiamyloidogenic | 0.218 0.088 CID_86055599 | CID_86055599 | |
| 0.047 | 0.084 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 CID_86055599 | CID_86055599 | |
| 0.153 | 0.191 | 0.179 | RNA-directed DNA polymerase inhibitor | 0.179 0.134 CID_86055599 | CID_86055599 | |
| 0.215 | 0.254 | 0.334 | Cyclophilin D inhibitor | 0.334 0.135 CID_86055599 | CID_86055599 | |
| 0.124 | 0.168 | 0.172 | Aldehyde oxidase inhibitor | 0.172 0.121 CID_86055599 | CID_86055599 | |
| 0.048 | 0.097 | 0.076 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.076 0.055 CID_86055599 | CID_86055599 | |
| 0.072 | 0.122 | 0.089 | Bile acid receptor antagonist | 0.089 0.077 CID_86055599 | CID_86055599 | |
| 0.103 | 0.154 | 0.14 | Arachidonic acid antagonist | 0.14 0.1 CID_86055599 | CID_86055599 | |
| 0.19 | 0.242 | 0.245 | Antibacterial | 0.245 0.181 CID_86055599 | CID_86055599 | |
| 0.158 | 0.217 | 0.241 | Transcription factor NF kappa B inhibitor | 0.241 0.134 CID_86055599 | CID_86055599 | |
| 0.042 | 0.103 | 0.085 | Porphobilinogen synthase inhibitor | 0.085 0.044 CID_86055599 | CID_86055599 | |
| 0.098 | 0.163 | 0.155 | Heat shock protein 90 antagonist | 0.155 0.07 CID_86055599 | CID_86055599 | |
| 0.164 | 0.237 | 0.213 | Caspase 3 stimulant | 0.213 0.151 CID_86055599 | CID_86055599 | |
| 0.073 | 0.156 | 0.111 | DOPA decarboxylase inhibitor | 0.111 0.057 CID_86055599 | CID_86055599 | |
| 0.113 | 0.199 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.124 CID_86055599 | CID_86055599 | |
| 0.02 | 0.115 | 0.056 | Xanthine dehydrogenase inhibitor | 0.056 0.041 CID_86055599 | CID_86055599 | |
| 0.046 | 0.142 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.049 CID_86055599 | CID_86055599 | |
| 0.093 | 0.21 | 0.126 | Melanin inhibitor | 0.126 0.122 CID_86055599 | CID_86055599 | |
| 0.122 | 0.24 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.153 0.141 CID_86055599 | CID_86055599 | |
| 0.125 | 0.252 | 0.195 | 12-Lipoxygenase inhibitor | 0.195 0.158 CID_86055599 | CID_86055599 | |
| 0.052 | 0.181 | 0.105 | Cystathionine beta-synthase inhibitor | 0.105 0.071 CID_86055599 | CID_86055599 | |
| 0.025 | 0.158 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 CID_86055599 | CID_86055599 | |
| 0.013 | 0.155 | 0.069 | Phosphodiesterase 3B inhibitor | 0.069 0.017 CID_86055599 | CID_86055599 | |
| 0.01 | 0.157 | 0.031 | Catechol O-methyltransferase inhibitor | 0.031 0.025 CID_86055599 | CID_86055599 | |
| 0.046 | 0.227 | 0.127 | Estrogen receptor beta antagonist | 0.127 0.025 CID_86055599 | CID_86055599 | |
| 0.052 | 0.267 | 0.135 | Estrogen antagonist | 0.135 0.033 CID_86055599 | CID_86055599 | |
| 0.05 | 0.327 | 0.116 | Interleukin 4 antagonist | 0.116 0.092 CID_86055599 | CID_86055599 | |
| 0.029 | 0.347 | 0.093 | Uric acid excretion stimulant | 0.093 0.061 CID_86055599 | CID_86055599 | |
| 0.02 | 0.339 | 0.092 | Phosphodiesterase 3A inhibitor | 0.092 0.039 CID_86055599 | CID_86055599 | |
| 0.106 | 0.452 | 0.212 | Interleukin 2 agonist | 0.212 0.169 CID_86055599 | CID_86055599 | |
| 0.117 | 0.485 | 0.28 | Antiinflammatory | 0.28 0.235 CID_86055599 | CID_86055599 | |
| 0.021 | 0.477 | 0.13 | Lipid peroxidase inhibitor | 0.13 0.084 CID_86055599 | CID_86055599 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |